We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT04080804
Brief Title: Study of Safety and Tolerability of Nivolumab Treatment Alone or in Combination With Relatlimab or Ipilimumab in Head and Neck Cancer

First Submitted : September 3, 2019
First Submitted that Met QC Criteria : September 3, 2019
First Posted : September 6, 2019

Last Update Submitted that Met QC Criteria : March 31, 2022
Last Update Posted : April 4, 2022